|
||||||
|
THE CURRENT TIME at LC Labs is: |
|||||
[AG 1478] [AG 1478 Mesylate]
|
Size |
US $ |
€ |
£ |
¥ |
|
||
|
25 mg |
49 |
41 |
27 |
5900 |
| ||
|
100 mg |
150 |
125 |
83 |
18000 |
| ||
|
500 mg |
590 |
490 |
325 |
70800 |
| ||
|
1 g |
985 |
818 |
542 |
118200 |
| ||
| Compare Quality and Prices LC Labs vs. Other Suppliers | |||
|---|---|---|---|
| US Dollars ($) | European Union Euros (€) | British Pounds (£) | Japanese Yen (¥) |
M.W. 411.87
C16H14ClN3O2CH4O3S
[175178-82-2]
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO up to about 25 mg/ml; poorly soluble in ethanol or water, but soluble in aqueous Captisol (see below). Appearance: White solid. Disposal: A
View the MSDS for this product
Very potent EGF receptor kinase (tyrosine kinase) inhibitor (IC50 = 3 nM). Very weak on PDGF receptor and HER2-NEU kinases (IC50 >100 µM). Osherov, N. and Levitzki, A. "Epidermal-growth-factor-dependent activation of the src-family kinases." Eur. J. Biochem. 225: 1047-1053 (1994). Levitzki, A. and Gazit, A. "Tyrosine kinase inhibition: an approach to drug development." Science 267: 1782-1788 (1995).
Reversibly inhibits (IC50 = 9.8 µM) the rat brain Kv1.5 potassium channel in vitro in a non-protein-tyrosine-kinase-mediated manner. Choi, B.H., et al. "Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor." Am. J. Physiol. Cell Physiol. 282: C1461-C1468 (2002).
Formulations for in vivo use. This product, the methanesulfonate (mesylate) salt of Tyrphostin AG 1478, can be conveniently formulated as a water-soluble complex with Captisol (β-cyclodextrin hepta-sulfobutyl ether). Captisol is available from Cydex (Lenexa, Kansas). Further details about Captisol solutions of Tyrphostin AG 1478 mesylate can be found in:
--Proc. Natl. Acad. Sci. USA 100: 15871-15876 (2003) Various concentrations of AG 1478 mesylate were dissolved in 100 mM Captisol for administration to mice via s.c., and i.p. injections.
--Biochem. Pharmacol. 71: 1422-1434 (2006) AG 1478 mesylate in Captisol was administered to mice by s.c. injection and to rats by i.v. injection.
--Anal. Biochem. 42: 292-299 (2005) These workers used 49 mM AG 1478 mesylate and 49 mM Captisol in aqueous solution to study the in vitro association of this drug with albumin.
--Clin. Cancer Res. 11: 7080s-7086s (2005) Here, AG 1478 mesylate at 4 mg/mL was dissolved in 100 mM Captisol and administered to nude mice by i.p. injection.
Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
© 1990-2008 LC Laboratories All rights reserved.